INS and major depressive disorder: All three exposure-outcome pairs had consistent point estimate effect directions, that is, a protective effect of fasting insulin on the risk of MDD (negative beta), a positive causal estimate between SZ and fasting insulin (positive beta), and a negative estimate between AN and HbA1c (negative beta).